Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-04

FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for SELZENTRY (maraviroc) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selzentry (Maraviroc)

Snippet

SUPPL AP for SELZENTRY (MARAVIROC)